Cornerstone Investment Partners’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
BAM
Cornerstone Investment Partners's ANGO Position: Q3 2025 in Review
Cornerstone Investment Partners sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 18,054 shares — an estimated $179K sold.
Cornerstone Investment Partners first reported a position in ANGO in Q1 2020 and held it in 4 quarters. The position peaked at $229K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.
- Cornerstone Investment Partners reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
- Cornerstone Investment Partners sold 18,054 AngioDynamics shares in Q3 2025, an estimated $179K.
- Cornerstone Investment Partners first reported a position in AngioDynamics in Q1 2020 and held it in 4 quarters.
- Cornerstone Investment Partners's AngioDynamics position peaked at $229K in Q4 2021.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.
Based on Cornerstone Investment Partners's 13F filing for Q3 2025, filed 6 Nov 2025.